Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Improving Lung Cancer Screening Rates and Smoking Documentation through Targeted Electronic Clinical Decision Support Travis Osterman Vanderbilt University Medical Center NLST Nov 2, 2015 NLST-173
Subset Analysis of Black Men Screened on the PLCO Prostate Cancer Screening Trial Curtiland Deville Johns Hopkins University PLCO Nov 2, 2015 PLCO-172
Examining the association between the dietary inflammatory index (DII) and pancreatic cancer risk and potential mediation by type-2 Diabetes Mellitus (DM) Susan Steck University of South Carolina PLCO Oct 23, 2015 PLCO-171
Computational tools for automatic ROI extraction in pathology Joƫlle Barral Google Life Sciences NLST Oct 23, 2015 NLST-171
Quantitative radiomic assessment of lung nodules with low dose CT Chuan Zhou University of Michigan NLST Oct 22, 2015 NLST-170
Computational tools for classification and histologic grading of lung cancer Ruijiang Li Stanford University NLST Oct 15, 2015 NLST-169
Abnormality Detection Ryan Chamberlain Invenshure LLC NLST Oct 8, 2015 NLST-168
The Autonomous Collection and Databasing of Cancer and Structural Specific Features Present in CT Based Cancer Images through mathematical imaging based Systems Jaffar Ali Shahul Hameed Florida Gulf Coast University NLST Oct 7, 2015 NLST-166
Virtual biopsy of pulmonary nodules Francesco Ciompi Radboud University Medical Center NLST Sep 30, 2015 NLST-164
Circulating inflammatory markers and urinary metabolites in combination with low dose computed tomography screening (LDCT). Curtis Harris NCI NLST Sep 25, 2015 NLST-165
Regional CT Parenchymal Abnormalities as Radiographic Biomarkers for Lung Cancer C. Matthew Kinsey University of Vermont College of Medicine NLST Sep 24, 2015 NLST-163
NLST screen detected cardiovascular disease - impact on mortality and lung cancer screening Martin Tammemagi Brock University NLST Sep 21, 2015 NLST-162
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The Operations Behind a Herculean Task Pam Marcus NCI PLCO Sep 16, 2015 PLCO-155
The importance of publishing on clinical trial operations Pam Marcus NCI PLCO Sep 16, 2015 PLCO-156
The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results Pam Marcus NCI PLCO Sep 16, 2015 PLCO-157
Building Successful Relationships in the PLCO Cancer Screening Trial Pam Marcus NCI PLCO Sep 16, 2015 PLCO-158
Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial Pam Marcus NCI PLCO Sep 16, 2015 PLCO-159
Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center Pam Marcus NCI PLCO Sep 16, 2015 PLCO-160
Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial Pam Marcus NCI PLCO Sep 16, 2015 PLCO-161
Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Pam Marcus NCI PLCO Sep 16, 2015 PLCO-162